SlideShare ist ein Scribd-Unternehmen logo
1 von 22
Downloaden Sie, um offline zu lesen
Stability testing
Stability Testing
PRESENTED BY
SANA IJAZ
10-M-PCEU-2014
Stability testing
 The purpose of stability testing is to provide evidence on how
the quality of an active pharmaceutical ingredient or
medicinal product varies with time under the influence of a
variety of environmental factors such as temperature,
humidity, and light, and to establish a re-test period for the
active pharmaceutical ingredient or a shelf life for the
medicinal product and recommended storage conditions.
Stability of drugs
 The ability of the pharmaceutical dosage form to
maintain the physical, chemical, therapeutic and
microbial properties during the time of storage and
usage by the patients.
 Stability include attributes of the active
pharmaceutical ingredient that are susceptible to
change during storage and are likely to influence
quality, safety, and/or efficacy.
Expiration date
 The date placed on the container label of a drug
product designated the time prior to which a batch of
the product is expected to remain with in the
approved shelf life specification, if stored under
defined conditions, and after which it must not be
used
Shelf life
 The time period during which a drug product is expected to
remain within the approved shelf life specification, provided
that it is stored under the conditions
 The time period during which the drug maintain its
90%potency or loss not more than 10% potency
Climate zones
 The design of the stability-testing programme should take into account
the intended market and the climatic conditions in the area in which the
medicinal products will be used.
 Four climatic zones can be distinguished:
 Zone 1:temperate
 Zone 2:subtropical, with possible high humidity
 Zone 3:hot/dry
 Zone 4:hot/humid
 The shelf life should be established with due regard to the climatic
zone(s) in which the products are to be marketed
Stress testing
 Stress testing of the active pharmaceutical ingredient can help identify
the likely degradation products, which can in turn help establish the
degradation pathways and the intrinsic stability of the molecule.
 Stress testing is likely to be carried out on single batch of the active
pharmaceutical ingredient. It should include the effect of temperature (in
10C increment) above that for accelerating testing , humidity (e.g., 75%
RH or greater) where appropriate oxidation and photolysis on the API.
 The testing should evaluate the susceptibility of the API to hydrolysis
across a wide range of pH values when in solution or suspension.
 Photo stability testing should be an integral part of stress testing
Storage conditions
 API should be evaluated under storage conditions (with
appropriate tolerance) that test its thermal stability and, if
applicable, its sensitivity to moisture.
General case
Minimum time period
covered
Storage conditionsStudy
12 months25ºC ± 2ºC/60% RH ± 5%
RH
or
30°C ± 2°C/65% RH ± 5%
RH
Long term
6 months30ºC ± 2ºC/65% RH ±
5%RH
Intermediate
6 months40ºC ± 2ºC/75% RH ± 5%
RH
Accelerated
 If long term studies are conducted at 25ºC ± 2ºC/60% RH ±
5% RH and “significant change” occurs at any time during 6
month testing at the accelerated storage condition, additional
testing at the intermediate storage condition should be
conducted and evaluated against significant change criteria.
 Significant change: failure to meet specification, loss of 5 % potency
Storage in a refrigerator
Minimum time period
covered
Storage conditionsstudy
12 months5ºC ± 3ºCLong
6 months25ºC ± 2ºC/60% RH ± 5%
RH
Accelerated
Storage in freezer
Minimum time period
covered
StorageStudy
12 months-20ºC ± 5ºCLong
Testing frequency
 For long term studies, frequency of testing should be
sufficient to establish the stability profile of the
pharmaceutical product.
 For products with a proposed shelf life of at least 12 months,
the frequency of testing at the long term storage condition
should normally be every 3 months over the first year, every
6 months over the second year, and annually thereafter
through the proposed shelf life.
FrequencyStudy
0,3,6 and one additional time pointAccelerated time points
0,3,6,9,12,18,24,36 monthsLong time points
Parameters checked during testing
 Dissolution/ release of pharmaceutical product
 Assay /percentage purity of pharmaceutical product
 Physical characters of pharmaceutical product
 pH (in case of liquid)
Accelerated test for stability
 When determining the chemical stability of a product, assay
employed should be sufficiently specific to distinguish
between the drug and its decomposition product.
 Acceleration of chemical decomposition is achieved by
 Raising the temperature of the preparation.
 The order of reaction for the decomposition process is
determined by plotting the appropriate function of
concentration against time and obtaining a linear relationship
 The reaction velocity constant, k, for the de composition at
each of the elevated temperature can be calculated from the
slope of the line
 The Arrhenius relationship is then employed to determine
the reaction velocity constant ,k, at room temperature.
 This is obtained from the linear plot of the log of determined
reaction velocity constant, k, against the reciprocal of
absolute temperature, which is extrapolated to room
temperature 25 C
Arrhenius equation and plot
Estimation of shelf life
 The value of k at 25 C substituted in the Arrhenius equation
and an estimate obtained of the time during which the
product will maintained the required quality or potency (shelf
life)
 Limitations: the predicted shelf life of a preparation will only
be valid if the accelerated test is carried out on the final
packaged product.
 Applied only those form of decomposition which increase
with rise in temperature.
References
 Q1A(R2) Stability Testing of New Drug Substances and Products
 Alfred martin, physical pharmacy ,edition (4)
 Bentley's text book of pharmaceutics edition (8)
Stability testing

Weitere ähnliche Inhalte

Was ist angesagt?

Stability studies of drugs
Stability studies of drugsStability studies of drugs
Stability studies of drugsPromila Sharan
 
ICH GUIDELINE SPECIFIC WITH Q SERIES
ICH GUIDELINE SPECIFIC WITH Q SERIESICH GUIDELINE SPECIFIC WITH Q SERIES
ICH GUIDELINE SPECIFIC WITH Q SERIESHEALY LAD
 
ICH-Stability of finished products
ICH-Stability of finished productsICH-Stability of finished products
ICH-Stability of finished productsArshad Khan
 
A presentation on regulatory guidelines for photostability testing
A presentation on regulatory guidelines for photostability testingA presentation on regulatory guidelines for photostability testing
A presentation on regulatory guidelines for photostability testingzaartab
 
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLC
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLCQUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLC
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLCAnupriyaNR
 
Stability and stability testing
Stability and stability testingStability and stability testing
Stability and stability testingSharon Vijayanand
 
Ich guidelines for stability studies 1
Ich guidelines for stability studies 1Ich guidelines for stability studies 1
Ich guidelines for stability studies 1priyanka odela
 
Supac - Guidance for Immediate Release Dosage Form
Supac - Guidance for Immediate Release Dosage FormSupac - Guidance for Immediate Release Dosage Form
Supac - Guidance for Immediate Release Dosage FormJubiliant Generics Limited
 
Quality control test for packaging material ,qc test for glass,metal,rubber
Quality control test for packaging material ,qc test for glass,metal,rubberQuality control test for packaging material ,qc test for glass,metal,rubber
Quality control test for packaging material ,qc test for glass,metal,rubberKunalPatel257
 
STABILITY STUDIES
STABILITY STUDIESSTABILITY STUDIES
STABILITY STUDIESROHIT
 
Pharmaceutical validation ppt Rahul Dalvi
Pharmaceutical validation ppt Rahul DalviPharmaceutical validation ppt Rahul Dalvi
Pharmaceutical validation ppt Rahul DalviRahul Dalvi
 
INTRODUCTION TO QUALITY BY DESIGN (QBD)
INTRODUCTION TO QUALITY BY DESIGN (QBD)INTRODUCTION TO QUALITY BY DESIGN (QBD)
INTRODUCTION TO QUALITY BY DESIGN (QBD)Chetan Pawar 2829
 

Was ist angesagt? (20)

Stability studies of drugs
Stability studies of drugsStability studies of drugs
Stability studies of drugs
 
Master formula record
Master formula recordMaster formula record
Master formula record
 
Stability study
Stability studyStability study
Stability study
 
ICH Stability testing of new drug substances and products QA (R2) - 2015
ICH Stability testing of new drug substances and products QA (R2) - 2015ICH Stability testing of new drug substances and products QA (R2) - 2015
ICH Stability testing of new drug substances and products QA (R2) - 2015
 
Q6 guidelines
Q6 guidelinesQ6 guidelines
Q6 guidelines
 
ICH GUIDELINE SPECIFIC WITH Q SERIES
ICH GUIDELINE SPECIFIC WITH Q SERIESICH GUIDELINE SPECIFIC WITH Q SERIES
ICH GUIDELINE SPECIFIC WITH Q SERIES
 
Stability studies
Stability studies Stability studies
Stability studies
 
ICH-Stability of finished products
ICH-Stability of finished productsICH-Stability of finished products
ICH-Stability of finished products
 
A presentation on regulatory guidelines for photostability testing
A presentation on regulatory guidelines for photostability testingA presentation on regulatory guidelines for photostability testing
A presentation on regulatory guidelines for photostability testing
 
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLC
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLCQUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLC
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLC
 
Stability and stability testing
Stability and stability testingStability and stability testing
Stability and stability testing
 
Ich guidelines for stability studies 1
Ich guidelines for stability studies 1Ich guidelines for stability studies 1
Ich guidelines for stability studies 1
 
Supac - Guidance for Immediate Release Dosage Form
Supac - Guidance for Immediate Release Dosage FormSupac - Guidance for Immediate Release Dosage Form
Supac - Guidance for Immediate Release Dosage Form
 
Quality control test for packaging material ,qc test for glass,metal,rubber
Quality control test for packaging material ,qc test for glass,metal,rubberQuality control test for packaging material ,qc test for glass,metal,rubber
Quality control test for packaging material ,qc test for glass,metal,rubber
 
PROCESS VALIDATION
PROCESS VALIDATIONPROCESS VALIDATION
PROCESS VALIDATION
 
STABILITY STUDIES
STABILITY STUDIESSTABILITY STUDIES
STABILITY STUDIES
 
PHOTOSTABILITY TESTING SEM I SEMINAR
PHOTOSTABILITY TESTING SEM I SEMINARPHOTOSTABILITY TESTING SEM I SEMINAR
PHOTOSTABILITY TESTING SEM I SEMINAR
 
Qualification of UV spectrophotometer
Qualification of UV spectrophotometer Qualification of UV spectrophotometer
Qualification of UV spectrophotometer
 
Pharmaceutical validation ppt Rahul Dalvi
Pharmaceutical validation ppt Rahul DalviPharmaceutical validation ppt Rahul Dalvi
Pharmaceutical validation ppt Rahul Dalvi
 
INTRODUCTION TO QUALITY BY DESIGN (QBD)
INTRODUCTION TO QUALITY BY DESIGN (QBD)INTRODUCTION TO QUALITY BY DESIGN (QBD)
INTRODUCTION TO QUALITY BY DESIGN (QBD)
 

Ähnlich wie Stability testing

Stability Testing Of Pharmaceutical Dosage Form
Stability Testing Of Pharmaceutical Dosage FormStability Testing Of Pharmaceutical Dosage Form
Stability Testing Of Pharmaceutical Dosage FormNirmalyaDutta3
 
Stability studies of drug ICH Q1
Stability studies of drug ICH Q1 Stability studies of drug ICH Q1
Stability studies of drug ICH Q1 Manali Parab
 
Power point presentation shweta patil.
Power point presentation shweta patil.Power point presentation shweta patil.
Power point presentation shweta patil.ceutics1315
 
ACCELERATED STABILITY STUDY
 ACCELERATED STABILITY STUDY ACCELERATED STABILITY STUDY
ACCELERATED STABILITY STUDYPratikkumarjain
 
Stability Testing During Product Development
Stability Testing During Product DevelopmentStability Testing During Product Development
Stability Testing During Product DevelopmentAl Riyad Hasan
 
Presentation on-stability-study of pharmaceutical product
Presentation on-stability-study of pharmaceutical productPresentation on-stability-study of pharmaceutical product
Presentation on-stability-study of pharmaceutical productMd Mohsin
 
New microsoft office power point presentation (4)
New microsoft office power point presentation (4)New microsoft office power point presentation (4)
New microsoft office power point presentation (4)SrinivasaReddy137
 
Stability testing of herbal natural products and its
Stability testing of herbal natural products and itsStability testing of herbal natural products and its
Stability testing of herbal natural products and itsSudhindraKini
 
Accelerated stability studes
Accelerated stability studesAccelerated stability studes
Accelerated stability studesSunil Boreddy Rx
 
STABILITY TESTING OF HERBAL NATURAL PRODUCTS
STABILITY TESTING OF HERBAL NATURAL PRODUCTSSTABILITY TESTING OF HERBAL NATURAL PRODUCTS
STABILITY TESTING OF HERBAL NATURAL PRODUCTSTejaswini Chandra
 
Seminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilSeminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilsahilhusen
 
Seminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilSeminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilsahilhusen
 
Presentation1rohitha reddy
Presentation1rohitha reddyPresentation1rohitha reddy
Presentation1rohitha reddyceutics1315
 

Ähnlich wie Stability testing (20)

Stability studies
Stability studiesStability studies
Stability studies
 
Stability Testing Of Pharmaceutical Dosage Form
Stability Testing Of Pharmaceutical Dosage FormStability Testing Of Pharmaceutical Dosage Form
Stability Testing Of Pharmaceutical Dosage Form
 
Accelerated stability studies
Accelerated stability studiesAccelerated stability studies
Accelerated stability studies
 
Stability study
Stability studyStability study
Stability study
 
STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptxSTABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
 
Stability studies of drug ICH Q1
Stability studies of drug ICH Q1 Stability studies of drug ICH Q1
Stability studies of drug ICH Q1
 
Power point presentation shweta patil.
Power point presentation shweta patil.Power point presentation shweta patil.
Power point presentation shweta patil.
 
Power point presentation shweta patil.
Power point presentation shweta patil.Power point presentation shweta patil.
Power point presentation shweta patil.
 
ACCELERATED STABILITY STUDY
 ACCELERATED STABILITY STUDY ACCELERATED STABILITY STUDY
ACCELERATED STABILITY STUDY
 
Stability Testing During Product Development
Stability Testing During Product DevelopmentStability Testing During Product Development
Stability Testing During Product Development
 
Presentation on-stability-study of pharmaceutical product
Presentation on-stability-study of pharmaceutical productPresentation on-stability-study of pharmaceutical product
Presentation on-stability-study of pharmaceutical product
 
New microsoft office power point presentation (4)
New microsoft office power point presentation (4)New microsoft office power point presentation (4)
New microsoft office power point presentation (4)
 
Stability testing of herbal natural products and its
Stability testing of herbal natural products and itsStability testing of herbal natural products and its
Stability testing of herbal natural products and its
 
Accelerated stability studes
Accelerated stability studesAccelerated stability studes
Accelerated stability studes
 
QMS stability testing.pptx
QMS  stability testing.pptxQMS  stability testing.pptx
QMS stability testing.pptx
 
STABILITY TESTING OF HERBAL NATURAL PRODUCTS
STABILITY TESTING OF HERBAL NATURAL PRODUCTSSTABILITY TESTING OF HERBAL NATURAL PRODUCTS
STABILITY TESTING OF HERBAL NATURAL PRODUCTS
 
Seminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilSeminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahil
 
Seminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilSeminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahil
 
Presentation1rohitha reddy
Presentation1rohitha reddyPresentation1rohitha reddy
Presentation1rohitha reddy
 
Presentation1rohitha reddy
Presentation1rohitha reddyPresentation1rohitha reddy
Presentation1rohitha reddy
 

Kürzlich hochgeladen

FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 

Kürzlich hochgeladen (20)

FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 

Stability testing

  • 3. Stability testing  The purpose of stability testing is to provide evidence on how the quality of an active pharmaceutical ingredient or medicinal product varies with time under the influence of a variety of environmental factors such as temperature, humidity, and light, and to establish a re-test period for the active pharmaceutical ingredient or a shelf life for the medicinal product and recommended storage conditions.
  • 4. Stability of drugs  The ability of the pharmaceutical dosage form to maintain the physical, chemical, therapeutic and microbial properties during the time of storage and usage by the patients.  Stability include attributes of the active pharmaceutical ingredient that are susceptible to change during storage and are likely to influence quality, safety, and/or efficacy.
  • 5. Expiration date  The date placed on the container label of a drug product designated the time prior to which a batch of the product is expected to remain with in the approved shelf life specification, if stored under defined conditions, and after which it must not be used
  • 6. Shelf life  The time period during which a drug product is expected to remain within the approved shelf life specification, provided that it is stored under the conditions  The time period during which the drug maintain its 90%potency or loss not more than 10% potency
  • 7. Climate zones  The design of the stability-testing programme should take into account the intended market and the climatic conditions in the area in which the medicinal products will be used.  Four climatic zones can be distinguished:  Zone 1:temperate  Zone 2:subtropical, with possible high humidity  Zone 3:hot/dry  Zone 4:hot/humid  The shelf life should be established with due regard to the climatic zone(s) in which the products are to be marketed
  • 8. Stress testing  Stress testing of the active pharmaceutical ingredient can help identify the likely degradation products, which can in turn help establish the degradation pathways and the intrinsic stability of the molecule.  Stress testing is likely to be carried out on single batch of the active pharmaceutical ingredient. It should include the effect of temperature (in 10C increment) above that for accelerating testing , humidity (e.g., 75% RH or greater) where appropriate oxidation and photolysis on the API.  The testing should evaluate the susceptibility of the API to hydrolysis across a wide range of pH values when in solution or suspension.  Photo stability testing should be an integral part of stress testing
  • 9. Storage conditions  API should be evaluated under storage conditions (with appropriate tolerance) that test its thermal stability and, if applicable, its sensitivity to moisture.
  • 10. General case Minimum time period covered Storage conditionsStudy 12 months25ºC ± 2ºC/60% RH ± 5% RH or 30°C ± 2°C/65% RH ± 5% RH Long term 6 months30ºC ± 2ºC/65% RH ± 5%RH Intermediate 6 months40ºC ± 2ºC/75% RH ± 5% RH Accelerated
  • 11.  If long term studies are conducted at 25ºC ± 2ºC/60% RH ± 5% RH and “significant change” occurs at any time during 6 month testing at the accelerated storage condition, additional testing at the intermediate storage condition should be conducted and evaluated against significant change criteria.  Significant change: failure to meet specification, loss of 5 % potency
  • 12. Storage in a refrigerator Minimum time period covered Storage conditionsstudy 12 months5ºC ± 3ºCLong 6 months25ºC ± 2ºC/60% RH ± 5% RH Accelerated
  • 13. Storage in freezer Minimum time period covered StorageStudy 12 months-20ºC ± 5ºCLong
  • 14. Testing frequency  For long term studies, frequency of testing should be sufficient to establish the stability profile of the pharmaceutical product.  For products with a proposed shelf life of at least 12 months, the frequency of testing at the long term storage condition should normally be every 3 months over the first year, every 6 months over the second year, and annually thereafter through the proposed shelf life.
  • 15. FrequencyStudy 0,3,6 and one additional time pointAccelerated time points 0,3,6,9,12,18,24,36 monthsLong time points
  • 16. Parameters checked during testing  Dissolution/ release of pharmaceutical product  Assay /percentage purity of pharmaceutical product  Physical characters of pharmaceutical product  pH (in case of liquid)
  • 17. Accelerated test for stability  When determining the chemical stability of a product, assay employed should be sufficiently specific to distinguish between the drug and its decomposition product.  Acceleration of chemical decomposition is achieved by  Raising the temperature of the preparation.  The order of reaction for the decomposition process is determined by plotting the appropriate function of concentration against time and obtaining a linear relationship
  • 18.  The reaction velocity constant, k, for the de composition at each of the elevated temperature can be calculated from the slope of the line  The Arrhenius relationship is then employed to determine the reaction velocity constant ,k, at room temperature.  This is obtained from the linear plot of the log of determined reaction velocity constant, k, against the reciprocal of absolute temperature, which is extrapolated to room temperature 25 C
  • 20. Estimation of shelf life  The value of k at 25 C substituted in the Arrhenius equation and an estimate obtained of the time during which the product will maintained the required quality or potency (shelf life)  Limitations: the predicted shelf life of a preparation will only be valid if the accelerated test is carried out on the final packaged product.  Applied only those form of decomposition which increase with rise in temperature.
  • 21. References  Q1A(R2) Stability Testing of New Drug Substances and Products  Alfred martin, physical pharmacy ,edition (4)  Bentley's text book of pharmaceutics edition (8)